The Prenatal And Newborn Genetic Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Prenatal And Newborn Genetic Testing Market?
The market size of prenatal and newborn genetic testing has been expanding quickly in the past few years. The market surged from $6.68 billion in 2024 and is predicted to rise to $7.61 billion in 2025, with a compound annual growth rate (CAGR) of 13.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Prenatal And Newborn Genetic Testing Industry?
The Prenatal And Newborn Genetic Testing Global Market is anticipated to reach $12.04 billion by 2029, expanding at a compound annual growth rate (CAGR) of 12.1%.
Download Your Free Sample of the 2025 Prenatal And Newborn Genetic Testing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Prenatal And Newborn Genetic Testing Market?
The key drivers in the prenatal and newborn genetic testing market are:
• Expansion of genetic test panels
• Increasing awareness about maternal health
• New screening guidelines for prenatal and newborns
• Rising concentration on rare diseases.
Global Market Segmentation: Identifying Major Prenatal And Newborn Genetic Testing Industry Segments
The prenatal and newborn genetic testing market covered in this report is segmented –
1) By Product Type: Consumables, Instruments
2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings
3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia
4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers
Pre-order the 2025 Prenatal And Newborn Genetic Testing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Prenatal And Newborn Genetic Testing Market?
The key trends in the prenatal and newborn genetic testing market are:
• The increasing utilization of non-invasive prenatal testing (NIPT) is shaping the market.
• The use of whole genome and exome sequencing is an emerging trend.
• The integration of artificial intelligence in this field is a significant development.
• There is a rising trend towards preimplantation genetic testing (PGT) and direct-to-consumer genetic testing.
Who Are the Top Competitors & Leading Players in the Prenatal And Newborn Genetic Testing Market?
Major companies in the prenatal and newborn genetic testing market are:
• F. Hoffmann-La Roche AG
• Novartis AG
• Sanofi S.A.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers AG
• Becton, Dickinson and Company
• Quest Diagnostic Incorporated
• Agilent Technologies Inc.
• Grifols S.A.
• Terumo Corporation
• Illumina Inc.
• PerkinElmer Genomics
• Quidel Corporation
• Bio-Rad Laboratories Inc.
• Qiagen NV
• Werfen S.A.
• DiaSorin S.p.A
• Nova Biomedical
• BGI Group
• Natera Inc.
• Trinity Biotech PLC
• Meridian Bioscience Inc.
• Sekisui Diagnostics
• Chembio Diagnostics
• PTS Diagnostics
• Ariosa Diagnostics Inc.
• AccuBioTech Co. Ltd.
• Sequenom Inc.
Regional Dominance: Which Area Leads the Global Prenatal And Newborn Genetic Testing Market?
North America was the largest region in the prenatal and newborn genetic testing market in 2024
